Related Experiment Video
Updated: Jul 6, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Comparison of pro B-natriuretic peptide in hypertensive patients with and without diastolic dysfunction
Yudistira P Santosa1, Anna Tjandrawati, Noormartany
1Department of Internal Medicine, Faculty of Medicine Atmajaya University, Jl. Pluit Raya no. 2, Jakarta. yudipsan@yahoo.com
Insights
N-terminal pro-B-type natriuretic peptide (NT-pro BNP) levels tend to be higher in hypertensive patients with diastolic dysfunction. This suggests NT-pro BNP may aid in detecting this cardiac condition.
Area of Science:
- Cardiology
- Biomarkers
- Hypertension Research
Background:
- Diastolic dysfunction is a common complication in hypertensive patients.
- Early detection of diastolic dysfunction is crucial for timely intervention and management.
- Current diagnostic methods may have limitations in widespread screening.
Purpose of the Study:
- To investigate the potential of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) as a biomarker for diastolic dysfunction.
- To evaluate the correlation between NT-pro BNP levels and the presence of diastolic dysfunction in hypertensive individuals.
Main Methods:
- A cohort of 39 hypertensive patients with normal systolic function underwent echocardiography.
- Diastolic dysfunction was identified based on specific echocardiographic mitral flow patterns.
- NT-pro BNP levels were measured using electrochemiluminescence immunoassay (ECLIA).
Main Results:
- Twelve out of 39 subjects exhibited normal diastolic function.
- NT-pro BNP levels were observed to be marginally higher in the group with diastolic dysfunction (P=0.053).
- Baseline characteristics were comparable between groups, except for uric acid levels.
Conclusions:
- NT-pro BNP levels show a trend towards elevation in hypertensive patients with diastolic dysfunction.
- NT-pro BNP may serve as a potential, non-invasive indicator for diastolic dysfunction in this population.
- Further research is warranted to confirm the diagnostic utility of NT-pro BNP for diastolic dysfunction.
Aim:
to evaluate whether pro BNP can be used for detection of diastolic dysfunction.
Methods:
thirty nine hypertensive patients with normal systolic function, consecutively referred for echocardiography examination between October and December 2004 were recruited in the study. Diastolic dysfunction was diagnosed when echocardiographic mitral flow pattern demonstrated impaired relaxation, pseudonormalization or restrictive like patterns. NT-pro BNP levels were assessed using electro chemiluminescence Immunoassay (ECLIA) method. Unpaired t test was used to analyze the results.
Results:
twelve out of thirty nine subjects had normal diastolic function. All base line characteristics, except for uric acid, were equally distributed between normal and abnormal diastolic function group. NT-pro BNP levels were nearly significantly higher in the diastolic dysfunction group (P=0.053).
Conclusion:
NT-pro BNP levels trends to be higher in hypertensive subjects with diastolic dysfunction.
Related Concept Videos
Heart Failure II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of Diuretics
